Refining clinically relevant cut-offs of prostate specific antigen density for risk stratification in patients with PI-RADS 3 lesions.
AuteursMjaess G, Haddad L, Jabbour T, Baudewyns A, Bourgeno HA, Lefebvre Y, Ferriero M, Simone G, Fourcade A, Fournier G, Oderda M, Gontero P, Bernal-Gomez A, Mastrorosa A, Roche JB, Abou Zahr R, Ploussard G, Fiard G, Halinski A, Rysankova K, Dariane C, Delavar G, Anract J, Barry Delongchamps N, Bui AP, Taha F, Windisch O, Benamran D, Assenmacher G, Benijts J, Guenzel K, Roumeguère T, Peltier A, Diamand R
Peri-operative Chemotherapy and Immunotherapy to Optimize Cystectomy Outcomes in the Curative Intent of Non-Metastatic Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.
Humoral immune response against SARS-CoV-2 after adapted COVID-19 vaccine schedules in healthy adults: The IMCOVAS randomized clinical trial.
AuteursSteenackers K, Hanning N, Bruckers L, Desombere I, Marchant A, Ariën KK, Georges D, Soentjens P, D'Onofrio V, Hites M, Berens-Riha N, De Coster I, Damme PV
